SCHEMBL19782974

SCHEMBL19782974

Nc1nc2c(Cl)c(F)c(O)cc2s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
LMNA P02545 2/20 0.53
NSD1 Q96L73 2/20 0.50
PDPK1 O15530 1/20 0.45
NSD2 O96028 1/20 0.41
NSD3 Q9BZ95 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HSD17B10 Q99714 1/20 0.41
PDE10A Q9Y233 1/20 0.41
HTT P42858 2/20 0.38
AXL P30530 1/20 0.38
GFER P55789 1/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP2C19 P33261 1/20 0.36
KCNH2 Q12809 1/20 0.33
CYP3A4 P08684 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
PIK3CD O00329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL30189638 0.98 ALDH1A1 (0.51) ALDH1A1LMNANSD1PDPK1NSD2
Bromide SCHEMBL28941138 0.98 ALDH1A1 (0.51) ALDH1A1LMNANSD1PDPK1NSD2
SCHEMBL19782755 0.81 NSD1 (0.37) ALDH1A1LMNANSD1GAA
SCHEMBL19783088 0.76 CYP3A4 (0.49) ALDH1A1LMNANSD1SMN1; SMN2HSD17B10
SCHEMBL21099720 0.74 ALDH1A1 (0.68) ALDH1A1LMNANSD1PDPK1NSD2
SCHEMBL8309525 0.70 ALDH1A1 (0.68) ALDH1A1LMNANSD1PDPK1NSD2
SCHEMBL21091395 0.70 NSD1 (0.54) ALDH1A1LMNANSD1PDPK1NSD2
SCHEMBL19783184 0.70 LMNA (0.43) ALDH1A1LMNAHSD17B10GAAKCNH2
SCHEMBL12957508 0.69 NSD1 (0.68) ALDH1A1LMNANSD1PDPK1NSD2
SCHEMBL21753703 0.69 ALDH1A1 (1.00) ALDH1A1LMNANSD1PDPK1NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 ALDH1A1 1618/4885LMNA 745/4885NSD1 3520/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 ALDH1A1 1598/4885LMNA 603/4885NSD1 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.